These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 8571322)

  • 1. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
    Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
    Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
    Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F
    Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a monoclonal antibody directed against the carboxyl-terminus of human factor XIII. An epitope exposed upon denaturation and conserved across species lines.
    Song Y; Taubenfeld SM; Sheng D; Matsueda GR
    Thromb Haemost; 1994 Jan; 71(1):62-7. PubMed ID: 7513094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
    Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
    Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D; Matsueda GR; Haber E; Reed GL
    Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
    Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A thiocholine ester of cinnamic acid inhibits crosslinking of fibrin without specific binding to donor lysines.
    Perret BA; Seelich T; Furlan M; Beck EA
    Thromb Haemost; 1979 Jun; 41(4):695-701. PubMed ID: 483243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
    Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
    Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
    Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
    Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of fibrinogen crosslinking sites in the absence of thrombin.
    Seelich T; Furlan M; Beck EA
    Thromb Haemost; 1976 Jun; 35(3):620-7. PubMed ID: 10637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen.
    Siebenlist KR; Mosesson MW
    Biochemistry; 1996 May; 35(18):5817-21. PubMed ID: 8639542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of fibrin polymerization with monoclonal antibodies.
    Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
    Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.